Coler, Rhea N.
University of Washington · Seattle Children's Research Institute
8 papers on CoChatORCID 0000-0001-6974-5666
Most cited papers
- Verified
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 3,237
- Verified
Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
Pegu, A., O’Connell, S. E., Schmidt, S. D., O’Dell, S., Talana, C. A., Lai, L., Albert, J., Anderson, E., Bennett, H., Corbett, K. S., et al. (2021) · Science
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 527
- Verified
A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika
Erasmus, J. H., Khandhar, A. P., Guderian, J., Granger, B., Archer, J., Archer, M., Gage, E., Fuerte-Stone, J., Larson, E., Lin, S., et al. (2018) · Molecular Therapy
RNA Interference and Gene DeliveryMosquito-borne diseases and control
Cited by 161
- Verified
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
Lyke, K. E., Atmar, R. L., Islas, C. D., Posavad, C. M., Szydlo, D., Paul Chourdhury, R., Deming, M. E., Eaton, A., Jackson, L. A., Branche, A. R., et al. (2022) · Cell Reports Medicine
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 153
- Verified
Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection
Erasmus, J. H., Archer, J., Fuerte-Stone, J., Khandhar, A. P., Voigt, E., Granger, B., Bombardi, R. G., Govero, J., Tan, Q., Durnell, L. A., et al. (2020) · Molecular Therapy - Methods & Clinical Development
RNA Interference and Gene DeliveryMosquito-borne diseases and control
Cited by 118
- Verified
A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
Van Hoeven, N., Fox, C. B., Granger, B., Evers, T., Joshi, S. W., Nana, G. I., Evans, S. C., Lin, S., Liang, H., Liang, L., et al. (2017) · Scientific Reports
Influenza Virus Research StudiesImmunotherapy and Immune Responses
Cited by 87
- Verified
An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis
Larsen, S. E., Erasmus, J. H., Reese, V. A., Pecor, T., Archer, J., Kandahar, A., Hsu, F.-C., Nicholes, K., Reed, S. G., Baldwin, S. L., et al. (2023) · Vaccines
Tuberculosis Research and EpidemiologyImmune responses and vaccinations
Cited by 66
- Verified
The stimulatory effect of the TLR4-mediated adjuvant glucopyranosyl lipid A is well preserved in old age
Weinberger, B., Joos, C., Reed, S. G., Coler, R., & Grubeck-Loebenstein, B. (2016) · Biogerontology
Immunotherapy and Immune ResponsesImmune Response and Inflammation
Cited by 19
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free